Apple has reportedly acquired Tueo Health, a startup that was working on developing a system to help parents monitor asthma symptoms in sleeping children, reports CNBC.
It’s unclear how much Apple paid for Tueo Health. The start-up raised a small seed round of $1.1 million in funding in 2017. Tueo’s CEO and co-founder Bronwyn Harris and chief operating officer Anura Patil changed their employer to Apple on their LinkedIn profiles in late 2018, which is likely around the time Apple completed its acquisition of the company.
Co-founder Bronwyn Harris described the company's product in an interview with Stanford Biodesign.
"We use commercially available sensors to monitor asthmatic children while they sleep. Our technology leverages the data from these sensors to create a personalized baseline for each child. Alerts are automatically sent to parents when there are deviations from their child’s baseline. These alerts are interactive and informative – we provide contextual information and just-in-time education and support to help them better manage their child's asthma."
Bronwyn said the company planned to eventually expand to helping adults as well.
"In parallel with our commercial rollout, we’ll be expanding our technology to help adults with asthma. After that, we plan to tackle chronic obstructive pulmonary disease, which is another condition that doesn’t have a good measure of control."
More details in the full report linked below...
Read More
It’s unclear how much Apple paid for Tueo Health. The start-up raised a small seed round of $1.1 million in funding in 2017. Tueo’s CEO and co-founder Bronwyn Harris and chief operating officer Anura Patil changed their employer to Apple on their LinkedIn profiles in late 2018, which is likely around the time Apple completed its acquisition of the company.
Co-founder Bronwyn Harris described the company's product in an interview with Stanford Biodesign.
"We use commercially available sensors to monitor asthmatic children while they sleep. Our technology leverages the data from these sensors to create a personalized baseline for each child. Alerts are automatically sent to parents when there are deviations from their child’s baseline. These alerts are interactive and informative – we provide contextual information and just-in-time education and support to help them better manage their child's asthma."
Bronwyn said the company planned to eventually expand to helping adults as well.
"In parallel with our commercial rollout, we’ll be expanding our technology to help adults with asthma. After that, we plan to tackle chronic obstructive pulmonary disease, which is another condition that doesn’t have a good measure of control."
More details in the full report linked below...
Read More